<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1210" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1210/" /><meta name="ncbi_pagename" content="Spastic Paraplegia 11 - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Spastic Paraplegia 11 - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Spastic Paraplegia 11" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/12/19" /><meta name="citation_author" content="Giovanni Stevanin" /><meta name="citation_pmid" content="20301389" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1210/" /><meta name="citation_keywords" content="SPG 11" /><meta name="citation_keywords" content="SPG11" /><meta name="citation_keywords" content="Spatacsin" /><meta name="citation_keywords" content="SPG11" /><meta name="citation_keywords" content="Spastic Paraplegia 11" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Spastic Paraplegia 11" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Giovanni Stevanin" /><meta name="DC.Date" content="2019/12/19" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1210/" /><meta name="description" content="Spastic paraplegia 11 (SPG11) is characterized by progressive spasticity and weakness of the lower limbs frequently associated with the following: mild intellectual disability with learning difficulties in childhood and/or progressive cognitive decline; peripheral neuropathy; pseudobulbar involvement; and increased reflexes in the upper limbs. Less frequent findings include: cerebellar signs (ataxia, nystagmus, saccadic pursuit); retinal degeneration; pes cavus; scoliosis; and parkinsonism with characteristic brain MRI features that include thinning of the corpus callosum. Onset occurs mainly during infancy or adolescence (range: age 1-31 years) and in rare cases as late as age 60 years. Most affected individuals become wheelchair bound one or two decades after disease onset." /><meta name="og:title" content="Spastic Paraplegia 11" /><meta name="og:type" content="book" /><meta name="og:description" content="Spastic paraplegia 11 (SPG11) is characterized by progressive spasticity and weakness of the lower limbs frequently associated with the following: mild intellectual disability with learning difficulties in childhood and/or progressive cognitive decline; peripheral neuropathy; pseudobulbar involvement; and increased reflexes in the upper limbs. Less frequent findings include: cerebellar signs (ataxia, nystagmus, saccadic pursuit); retinal degeneration; pes cavus; scoliosis; and parkinsonism with characteristic brain MRI features that include thinning of the corpus callosum. Onset occurs mainly during infancy or adolescence (range: age 1-31 years) and in rare cases as late as age 60 years. Most affected individuals become wheelchair bound one or two decades after disease onset." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1210/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/spg11/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1210/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE88938CE04223D10000000003990163.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1210_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1210_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/spg8/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/kennedy/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1210_"><span class="title" itemprop="name">Spastic Paraplegia 11</span></h1><p class="contrib-group"><span itemprop="author">Giovanni Stevanin</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1210_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1210_ai__"><div class="contrib half_rhythm"><span itemprop="author">Giovanni Stevanin</span>, PhD<div class="affiliation small">Institut du Cerveau et de la Moelle Epini&#x000e8;re<br />INSERM, CNRS<br />Sorbonne University;<br />&#x000c9;cole Pratique des Hautes &#x000c9;tudes<br />Paris Sciences et Lettres Research University<br />H&#x000f4;pital Piti&#x000e9;-Salp&#x000ea;tri&#x000e8;re<br />Paris, France<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rf.cmpu@ninavets.innavoig" class="oemail">rf.cmpu@ninavets.innavoig</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">March 27, 2008</span>; Last Update: <span itemprop="dateModified">December 19, 2019</span>.</p><p><em>Estimated reading time: 16 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="spg11.Summary" itemprop="description"><h2 id="_spg11_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Spastic paraplegia 11 (SPG11) is characterized by progressive spasticity and weakness of the lower limbs frequently associated with the following: mild intellectual disability with learning difficulties in childhood and/or progressive cognitive decline; peripheral neuropathy; pseudobulbar involvement; and increased reflexes in the upper limbs. Less frequent findings include: cerebellar signs (ataxia, nystagmus, saccadic pursuit); retinal degeneration; <i>pes cavus</i>; scoliosis; and parkinsonism with characteristic brain MRI features that include thinning of the corpus callosum. Onset occurs mainly during infancy or adolescence (range: age 1-31 years) and in rare cases as late as age 60 years. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals become wheelchair bound one or two decades after disease onset.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of SPG11 is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with characteristic clinical and MRI findings and <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>SPG11</i> identified on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Care by a multidisciplinary team; physiotherapy to stretch spastic muscles; antispastic drugs such as baclofen; botulin toxin and intrathecal baclofen for severe and disabling spasticity when oral drugs are ineffective. Urodynamic evaluation when bladder dysfunction is evident; anticholinergic drugs for urinary urgency. Treatment of psychiatric manifestations by standard protocols.</p><p><i>Prevention of secondary complications:</i> Treatment of sphincter disturbances to prevent urinary tract infection secondary to bladder dysfunction.</p><p><i>Surveillance:</i> Evaluation every six months to adjust physiotherapy and medications.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>SPG11 is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. If each parent is known to be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for an <i>SPG11</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has at conception a 25% chance of being affected, a 50% chance of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk family members and prenatal testing for at-risk pregnancies are possible once the pathogenic variants in a family are known.</p></div></div><div id="spg11.Diagnosis"><h2 id="_spg11_Diagnosis_">Diagnosis</h2><div id="spg11.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Spastic paraplegia 11 (SPG11) <b>should be suspected</b> in individuals with the following clinical and imaging findings.</p><p><b>Frequent clinical findings</b></p><ul><li class="half_rhythm"><div>Progressive spasticity and weakness of the lower limbs</div></li><li class="half_rhythm"><div>Mild intellectual disability with learning difficulties in childhood and/or progressive cognitive decline with onset in the first to third decade</div></li><li class="half_rhythm"><div>Axonal, motor, or sensorimotor peripheral neuropathy (&#x0003e;80% of individuals) [<a class="bk_pop" href="#spg11.REF.stevanin.2008.772">Stevanin et al 2008</a>, <a class="bk_pop" href="#spg11.REF.orlacchio.2010.591">Orlacchio et al 2010</a>, <a class="bk_pop" href="#spg11.REF.daoud.2012.839.e5">Daoud et al 2012</a>, <a class="bk_pop" href="#spg11.REF._zo_uz.2015.1764.e9">&#x000d6;zo&#x0011f;uz et al 2015</a>, <a class="bk_pop" href="#spg11.REF.manole.2016.2278">Manole et al 2016</a>, <a class="bk_pop" href="#spg11.REF.montecchiani.2016.73">Montecchiani et al 2016</a>]</div></li><li class="half_rhythm"><div>Pseudobulbar involvement with dysarthria and/or dysphagia</div></li><li class="half_rhythm"><div>Increased reflexes in the upper limbs</div></li></ul><p><b>Less frequent clinical findings</b></p><ul><li class="half_rhythm"><div>Cerebellar signs (ataxia or ocular signs including nystagmus and/or saccadic pursuit)</div></li><li class="half_rhythm"><div>Retinal degeneration (Kjellin syndrome)&#x000a0;* [<a class="bk_pop" href="#spg11.REF.puech.2011.564">Puech et al 2011</a>]</div></li><li class="half_rhythm"><div><i>Pes cavus</i></div></li><li class="half_rhythm"><div>Scoliosis</div></li><li class="half_rhythm"><div>Extrapyramidal signs such as parkinsonism [<a class="bk_pop" href="#spg11.REF.anheim.2009.104">Anheim et al 2009</a>, <a class="bk_pop" href="#spg11.REF.faber.2018a.1650">Faber et al 2018a</a>]</div></li></ul><p>*&#x000a0;Kjellin syndrome is characterized by retinal degeneration, <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> hereditary spastic paraplegia, and thin corpus callosum initially associated with spastic paraplegia 15 (SPG15) but more often occurring in individuals with SPG11.</p><p><b>Imaging findings on brain and spinal cord MRI</b></p><ul><li class="half_rhythm"><div>Thinning of the corpus callosum (TCC) (&#x0003e;90% of individuals) [<a class="bk_pop" href="#spg11.REF.stevanin.2008.772">Stevanin et al 2008</a>] particularly with long T<sub>1</sub> and T<sub>2</sub> values in the forceps minor of the corpus callosum, the so-called &#x0201c;ear of the lynx&#x0201d; sign which appears hyperintense on FLAIR and hypointense on T<sub>1</sub>-weighted images [<a class="bk_pop" href="#spg11.REF.pascual.2019.199">Pascual et al 2019</a>]</div></li><li class="half_rhythm"><div>Cortical atrophy is frequently observed.</div></li><li class="half_rhythm"><div>White matter hyperintensities [<a class="bk_pop" href="#spg11.REF.fran_a.2012.828">Fran&#x000e7;a et al 2012</a>]</div><ul><li class="half_rhythm"><div>Only frontal and occipital periventricular hyperintensities may be seen initially.</div></li><li class="half_rhythm"><div>Periventricular, confluent leukoencephalopathy often increases in severity with disease duration [<a class="bk_pop" href="#spg11.REF.hehr.2007.656">Hehr et al 2007</a>, <a class="bk_pop" href="#spg11.REF.stevanin.2008.772">Stevanin et al 2008</a>].</div></li></ul></li><li class="half_rhythm"><div>Atrophy of both the brain stem and the cerebellum can be observed [<a class="bk_pop" href="#spg11.REF.stevanin.2007.366">Stevanin et al 2007</a>].</div></li><li class="half_rhythm"><div>The basal ganglia may also be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> [<a class="bk_pop" href="#spg11.REF.faber.2018b.848">Faber et al 2018b</a>].</div></li></ul><p>Note: 60% of individuals with TCC, cognitive impairment, and spastic paraparesis were found to have <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>SPG11</i> pathogenic variants [<a class="bk_pop" href="#spg11.REF.stevanin.2008.772">Stevanin et al 2008</a>].</p></div><div id="spg11.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of spastic paraplegia 11 (SPG11) <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>SPG11</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1210/table/spg11.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figspg11Tmoleculargenetictestingusedi" rid-ob="figobspg11Tmoleculargenetictestingusedi">Table 1</a>).</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of SPG11 is broad, individuals with the distinctive findings described in <a href="#spg11.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#spg11.Option_1">Option 1</a>), whereas those with a phenotype indistinguishable from many other inherited disorders with spastic paraplegia are more likely to be diagnosed using genomic testing (see <a href="#spg11.Option_2">Option 2</a>).</p><div id="spg11.Option_1"><h4>Option 1</h4><p>When the phenotypic, imaging, and electrophysiology findings suggest the diagnosis of SPG11, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>SPG11</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected. Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first. If only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, perform gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications. Of note, 10%-20% of disease-associated variants are exon-sized or larger deletions and duplications [<a class="bk_pop" href="#spg11.REF.g_nther.2016.703">G&#x000fc;nther et al 2016</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A spastic paraplegia</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>SPG11</i> and other genes of interest (see <a href="#spg11.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For this disorder a multigene panel that also includes deletion/duplication analysis is recommended (see <a class="figpopup" href="/books/NBK1210/table/spg11.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figspg11Tmoleculargenetictestingusedi" rid-ob="figobspg11Tmoleculargenetictestingusedi">Table 1</a>).</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="spg11.Option_2"><h4>Option 2</h4><p>When the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is indistinguishable from many other inherited disorders characterized by spastic paraplegia, <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>If <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a> (when clinically available) may be considered to detect (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="spg11.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Spastic Paraplegia 11</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1210/table/spg11.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__spg11.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_spg11.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_spg11.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_spg11.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_spg11.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SPG11</i></td><td headers="hd_h_spg11.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_spg11.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~81%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_spg11.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_spg11.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~19%&#x000a0;<sup>4</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="spg11.TF.1.1"><p class="no_margin">See <a href="/books/NBK1210/#spg11.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="spg11.TF.1.2"><p class="no_margin">See <a href="#spg11.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="spg11.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="spg11.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#spg11.REF.g_nther.2016.703">G&#x000fc;nther et al [2016]</a></p></div></dd><dt>5. </dt><dd><div id="spg11.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd></dl></div></div></div></div></div></div><div id="spg11.Clinical_Characteristics"><h2 id="_spg11_Clinical_Characteristics_">Clinical Characteristics</h2><div id="spg11.Clinical_Description"><h3>Clinical Description</h3><p>Onset of spastic paraplegia 11 (SPG11) occurs mainly during infancy or adolescence (age 1-31 years) and is characterized by gait disorders or less frequently by intellectual disability [<a class="bk_pop" href="#spg11.REF.stevanin.2007.366">Stevanin et al 2007</a>, <a class="bk_pop" href="#spg11.REF.stevanin.2008.772">Stevanin et al 2008</a>, <a class="bk_pop" href="#spg11.REF.kara.2016.1904">Kara et al 2016</a>]. Later onset (age 50-60 years) was reported in a few individuals [<a class="bk_pop" href="#spg11.REF.rubegni.2015.1987">Rubegni et al 2015</a>, <a class="bk_pop" href="#spg11.REF.kawarai.2015.250">Kawarai et al 2015</a>].</p><p>Approximately ten years after onset, most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have the complete clinical picture of SPG11, including progressive lower-limb spasticity, atrophy of the corpus callosum with intellectual disability, and/or progressive cognitive decline. Thinning of the corpus callosum appears to correlate with disease severity [<a class="bk_pop" href="#spg11.REF.kara.2016.1904">Kara et al 2016</a>]. Most affected individuals become wheelchair bound one or two decades after disease onset [<a class="bk_pop" href="#spg11.REF.stevanin.2008.772">Stevanin et al 2008</a>, <a class="bk_pop" href="#spg11.REF.puech.2011.564">Puech et al 2011</a>].</p><p>Cognitive decline with low Mini Mental State Evaluation (MMSE) scores, found in the majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, worsens with time and includes severe short-term memory impairment, emotional lability, childish behavior, reduced verbal fluency, and attention deficit indicative of executive dysfunction [<a class="bk_pop" href="#spg11.REF.hehr.2007.656">Hehr et al 2007</a>, <a class="bk_pop" href="#spg11.REF.stevanin.2008.772">Stevanin et al 2008</a>]. Psychiatric problems with behavioral disturbances are observed. Most individuals with SPG11 display little concern over the progression of their motor disease [<a class="bk_pop" href="#spg11.REF.stevanin.2008.772">Stevanin et al 2008</a>]. All these findings correlate with the frontal atrophy detected on follow-up brain MRI.</p><p>Intellectual disability, found in most individuals with early onset, is characterized by learning difficulties in childhood and low IQ.</p><p>Eye findings can include the following:</p><ul><li class="half_rhythm"><div>Macular excavation or degeneration as reported in the Kjellin syndrome [<a class="bk_pop" href="#spg11.REF.orl_n.2009.984">Orl&#x000e9;n et al 2009</a>, <a class="bk_pop" href="#spg11.REF.puech.2011.564">Puech et al 2011</a>]</div></li><li class="half_rhythm"><div>Strabismus</div></li><li class="half_rhythm"><div>Cerebellar ocular signs such as abnormal saccadic pursuit and nystagmus in individuals with the longest disease duration</div></li><li class="half_rhythm"><div>Visual evoked potentials with increased latencies and decreased amplitudes [<a class="bk_pop" href="#spg11.REF.stevanin.2008.772">Stevanin et al 2008</a>]</div></li></ul><p>Additional features are severe weakness, dysarthria, distal or generalized muscle wasting, and less frequently, <i>pes cavus</i>, scoliosis, parkinsonism, epilepsy, and orthostatic hypotension [<a class="bk_pop" href="#spg11.REF.kara.2016.1904">Kara et al 2016</a>]. Individuals with the longest disease duration may have swallowing difficulties [<a class="bk_pop" href="#spg11.REF.stevanin.2008.772">Stevanin et al 2008</a>].</p><p><b>Electromyography (EMG) and nerve conduction velocities (NCVs)</b> frequently show signs of axonal sensorimotor neuropathy particularly when disease duration exceeds ten years [<a class="bk_pop" href="#spg11.REF.stevanin.2008.772">Stevanin et al 2008</a>].</p><p><b>Sural nerve biopsies</b> have shown loss of unmyelinated nerve fibers and accumulation of pleomorphic membranous material in unmyelinated axons [<a class="bk_pop" href="#spg11.REF.hehr.2007.656">Hehr et al 2007</a>].</p></div><div id="spg11.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Missense and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants are more often associated with later onset [<a class="bk_pop" href="#spg11.REF.kawarai.2015.250">Kawarai et al 2015</a>, <a class="bk_pop" href="#spg11.REF.rubegni.2015.1987">Rubegni et al 2015</a>] and mild disease severity [<a class="bk_pop" href="#spg11.REF.kara.2016.1904">Kara et al 2016</a>].</p></div><div id="spg11.Nomenclature"><h3>Nomenclature</h3><p>SPG11 is one of several <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorders in which hereditary spastic paraplegia is associated with thin corpus callosum (HSP-TCC).</p><p>Based on the EMG and NCV patterns and on anterior horn cell abnormalities seen in some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, several authors have characterized SPG11 as upper and lower motor neuron disease [<a class="bk_pop" href="#spg11.REF.stevanin.2008.772">Stevanin et al 2008</a>], juvenile amyotrophic lateral sclerosis with long disease duration [<a class="bk_pop" href="#spg11.REF.orlacchio.2010.591">Orlacchio et al 2010</a>, <a class="bk_pop" href="#spg11.REF.daoud.2012.839.e5">Daoud et al 2012</a>, <a class="bk_pop" href="#spg11.REF._zo_uz.2015.1764.e9">&#x000d6;zo&#x0011f;uz et al 2015</a>, <a class="bk_pop" href="#spg11.REF.manole.2016.2278">Manole et al 2016</a>], or Charcot-Marie-Tooth neuropathy [<a class="bk_pop" href="#spg11.REF.montecchiani.2016.73">Montecchiani et al 2016</a>].</p></div><div id="spg11.Prevalence"><h3>Prevalence</h3><p>The estimated prevalence for HSP of all types ranges from 1:100,000 to 10:100,000 depending on the country. Since SPG11 was found to account for 19%-31% of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> HSP [<a class="bk_pop" href="#spg11.REF.stevanin.2008.772">Stevanin et al 2008</a>, <a class="bk_pop" href="#spg11.REF.kara.2016.1904">Kara et al, 2016</a>], a prevalence of 1.25:100,000 for SPG11 can be estimated.</p><p>As expected in <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorders, most families with SPG11 originate from countries in which <a class="def" href="/books/n/gene/glossary/def-item/consanguinity/">consanguinity</a> is common, particularly the Mediterranean basin or the Middle East [<a class="bk_pop" href="#spg11.REF.hehr.2007.656">Hehr et al 2007</a>, <a class="bk_pop" href="#spg11.REF.stevanin.2008.772">Stevanin et al 2008</a>, <a class="bk_pop" href="#spg11.REF.boukhris.2009.527">Boukhris et al 2009</a>, <a class="bk_pop" href="#spg11.REF.denora.2009.e500">Denora et al 2009</a>, <a class="bk_pop" href="#spg11.REF._zo_uz.2015.1764.e9">&#x000d6;zo&#x0011f;uz et al 2015</a>, <a class="bk_pop" href="#spg11.REF.kara.2016.1904">Kara et al 2016</a>]. However, SPG11 has been reported in families worldwide [<a class="bk_pop" href="#spg11.REF.hehr.2007.656">Hehr et al 2007</a>, <a class="bk_pop" href="#spg11.REF.stevanin.2007.366">Stevanin et al 2007</a>, <a class="bk_pop" href="#spg11.REF.southgate.2010.379">Southgate et al 2010</a>, <a class="bk_pop" href="#spg11.REF.rajakulendran.2011.102">Rajakulendran et al 2011</a>, <a class="bk_pop" href="#spg11.REF._zo_uz.2015.1764.e9">&#x000d6;zo&#x0011f;uz et al 2015</a>, <a class="bk_pop" href="#spg11.REF.kara.2016.1904">Kara et al 2016</a>].</p></div></div><div id="spg11.Genetically_Related_Allelic_Disord"><h2 id="_spg11_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p><i>SPG11</i> pathogenic variants are associated with a spectrum of clinical manifestations resulting from first and/or second motor neuron degeneration. This includes pure or complex HSP [<a class="bk_pop" href="#spg11.REF.stevanin.2008.772">Stevanin et al 2008</a>], amyotrophic lateral sclerosis [<a class="bk_pop" href="#spg11.REF.orlacchio.2010.591">Orlacchio et al 2010</a>, <a class="bk_pop" href="#spg11.REF.daoud.2012.839.e5">Daoud et al 2012</a>, <a class="bk_pop" href="#spg11.REF._zo_uz.2015.1764.e9">&#x000d6;zo&#x0011f;uz et al 2015</a>, <a class="bk_pop" href="#spg11.REF.manole.2016.2278">Manole et al 2016</a>] and Charcot-Marie-Tooth neuropathy [<a class="bk_pop" href="#spg11.REF.montecchiani.2016.73">Montecchiani et al 2016</a>], regardless of the nature of the pathogenic variants. Individuals with multiple sclerosis have also been found to have <i>SPG11</i> pathogenic variants [<a class="bk_pop" href="#spg11.REF.romagnolo.2014.e14">Romagnolo et al 2014</a>, <a class="bk_pop" href="#spg11.REF.mukai.2018.3183">Mukai et al 2018</a>].</p></div><div id="spg11.Differential_Diagnosis"><h2 id="_spg11_Differential_Diagnosis_">Differential Diagnosis</h2><p>See <a href="/books/n/gene/hsp/">Hereditary Spastic Paraplegia Overview</a>. The relative frequency of spastic paraplegia 11 (SPG11) varies according to <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and geographic origin. In Portugal, it accounts for 13% of all forms of spastic paraplegia regardless of the inheritance mode [<a class="bk_pop" href="#spg11.REF.morais.2017.1217">Morais et al 2017</a>]. SPG11 accounts for 5%-20% of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> spastic paraplegias [<a class="bk_pop" href="#spg11.REF.stevanin.2008.772">Stevanin et al 2008</a>] and up to 30%-50% of autosomal recessive complex spastic paraplegia [<a class="bk_pop" href="#spg11.REF.kara.2016.1904">Kara et al 2016</a>, <a class="bk_pop" href="#spg11.REF.morais.2017.1217">Morais et al 2017</a>]. This frequency increases up to 59%-70% [<a class="bk_pop" href="#spg11.REF.stevanin.2008.772">Stevanin et al 2008</a>, <a class="bk_pop" href="#spg11.REF.boukhris.2009.527">Boukhris et al 2009</a>, <a class="bk_pop" href="#spg11.REF.denora.2009.e500">Denora et al 2009</a>] when mental impairment and thinning of the corpus callosum are associated. <i>SPG11</i> pathogenic variants can be found in a small proportion of individuals with a pure spastic paraplegia (&#x0003c;10%) but disease duration usually fewer than five years [<a class="bk_pop" href="#spg11.REF.denora.2009.e500">Denora et al 2009</a>].</p><p>There are other forms of spastic paraplegia associated with thinning of the corpus callosum and mental impairment and it is often difficult to distinguish them from SPG11 on clinical grounds (<a class="figpopup" href="/books/NBK1210/table/spg11.T.other_hereditary_spastic_paraple/?report=objectonly" target="object" rid-figpopup="figspg11Totherhereditaryspasticparaple" rid-ob="figobspg11Totherhereditaryspasticparaple">Table 2</a>).</p><div id="spg11.T.other_hereditary_spastic_paraple" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Other Hereditary Spastic Paraplegias Associated with Thin Corpus Callosum (HSP-TCC) and Mental Impairment of Interest in the Differential Diagnosis of Spastic Paraplegia 11 (SPG11)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1210/table/spg11.T.other_hereditary_spastic_paraple/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__spg11.T.other_hereditary_spastic_paraple_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_2" style="text-align:left;vertical-align:middle;">Disorder&#x000a0;1</th><th id="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Clinical Features of Differential Diagnosis Disorder</th></tr><tr><th headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_4" id="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/SPG11</th><th headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_4" id="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from SPG11</th></tr></thead><tbody><tr><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AP4B1</i></td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SPG47</td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_3" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_4 hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_2_1" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;">Seizures; white matter abnormalities</td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_4 hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_2_2" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;">Severe ID; facial dysmorphism; microcephaly; stereotypic laughter w/tongue protrusion</td></tr><tr><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AP4M1</i></td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SPG50</td></tr><tr><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AP4E1</i></td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SPG51</td></tr><tr><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AP4S1</i></td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SPG52</td></tr><tr><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DDHD2</i></td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SPG54</td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_4 hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Leukodystrophy</td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_4 hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe DD</td></tr><tr><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ERLIN2</i></td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SPG18</td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_4 hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Also assoc w/epilepsy; DD</td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_4 hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Agenesis of corpus callosum</td></tr><tr><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SPG21</i></td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SPG21 (Mast syndrome)</td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_4 hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Late onset ataxia; adult-onset dementia &#x00026; parkinsonism; polyneuropathy</td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_4 hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Japanese &#x00026; Amish origin; akinetic mutism seen in advanced disease; psychiatric disease</td></tr><tr><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GBA2</i></td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SPG46</td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_4 hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">TCC; cerebellar &#x00026;cerebral atrophy; DD; cerebellar signs; polyneuropathy</td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_4 hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Congenital cataract; male infertility (hypogonadism)</td></tr><tr><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TECPR2</i></td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SPG49</td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_4 hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">TCC reported occasionally</td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_4 hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Central apnea; severe DD; microcephaly; <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features; gastroesophageal reflux</td></tr><tr><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ZFYVE26</i></td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SPG15</td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_4 hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DD; optic atrophy; ataxia; central retinal degeneration; polyneuropathy</td><td headers="hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_1_4 hd_h_spg11.T.other_hereditary_spastic_paraple_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No clinical features discriminate between SPG11 &#x00026; SPG15.</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; DD = developmental delay; HSP = hereditary spastic paraplegia; ID = intellectual disability; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; TCC = thin corpus callosum</p></div></dd><dt>1. </dt><dd><div id="spg11.TF.2.1"><p class="no_margin">See <a href="https://www.ncbi.nlm.nih.gov/books/n/gene/hsp/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hereditary Spastic Paraplegia Overview</a></p></div></dd></dl></div></div></div><p>Lower motor neuron degeneration may mimic <a href="/books/n/gene/als-overview/">amyotrophic lateral sclerosis</a> (ALS) when wasting is marked [<a class="bk_pop" href="#spg11.REF.stevanin.2008.772">Stevanin et al 2008</a>, <a class="bk_pop" href="#spg11.REF.orlacchio.2010.591">Orlacchio et al 2010</a>, <a class="bk_pop" href="#spg11.REF.daoud.2012.839.e5">Daoud et al 2012</a>]. The continuum between spastic paraplegia and ALS has been evidenced by the finding of lesions common to ALS in the brain of individuals with SPG11 [<a class="bk_pop" href="#spg11.REF.denora.2016.1723">Denora et al 2016</a>].</p></div><div id="spg11.Management"><h2 id="_spg11_Management_">Management</h2><div id="spg11.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with spastic paraplegia 11 (SPG11), the following evaluations (if not performed as part of the evaluation that led to the diagnosis) are recommended:</p><ul><li class="half_rhythm"><div>Neuropsychological testing to assess the cognitive impairment and decline</div></li><li class="half_rhythm"><div>Neuro-urologic examination for those with sphincter disturbance</div></li><li class="half_rhythm"><div>Electrophysiologic investigations (e.g., ENMG, VEP, SEP)</div></li><li class="half_rhythm"><div>Ocular investigations (e.g., funduscopic examination, OCT)</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="spg11.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>No specific drug treatment or cure exists for SPG11.</p><p>Care by a multidisciplinary team that may include a general practitioner, neurologist, clinical geneticist, physiotherapist, physical therapist, social worker, and psychologist should be considered.</p><p>Symptomatic treatment to reduce pyramidal hyperactivity in the lower limbs includes the following:</p><ul><li class="half_rhythm"><div>Physiotherapy for stretching of the spastic muscles to prevent contractures. Adapted dance or movements are also helpful to maintain strength (see <a href="https://www.clickanddance.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.clickanddance.com</a>).</div></li><li class="half_rhythm"><div>Antispastic drugs such as baclofen and tizanidine</div></li><li class="half_rhythm"><div>Botulin toxin and intrathecal baclofen, which can be considered when oral drugs are ineffective and spasticity is severe and disabling</div></li></ul><p>When sphincter disturbances become a problem, urodynamic evaluation should be performed in order to adapt treatment and monitor follow up. Anticholinergic drugs are indicated for urinary urgency.</p><p>Psychiatric manifestations should be treated in accordance with standard practice.</p></div><div id="spg11.Prevention_of_Secondary_Complicati"><h3>Prevention of Secondary Complications</h3><p>Follow up of sphincter disturbances is important to prevent bladder dysfunction and infection.</p><p>Early regular physiotherapy helps to prevent contractures.</p></div><div id="spg11.Surveillance"><h3>Surveillance</h3><p>Specialized outpatient clinic evaluations are suggested every six months to adjust medication and physical rehabilitation that will depend on disease severity.</p><p>Annual brain MRI can be used to follow the atrophy of the corpus callosum, cerebellum, and brain stem, and to monitor increases in the size and intensity of white matter hyperintensities.</p><p>Annual electrophysiologic investigations (e.g., ENMG, VEP, SEP) are recommended to follow the extent of the disease.</p><p>Visual acuity should be assessed annually.</p></div><div id="spg11.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#spg11.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="spg11.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="spg11.Genetic_Counseling"><h2 id="_spg11_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="spg11.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Spastic paraplegia 11 (SPG11) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="spg11.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div class="half_rhythm">In almost all cases, the parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are heterozygotes (i.e., carriers of one <i>SPG11</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div class="half_rhythm">Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> to confirm that each parent is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>SPG11</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and allow for reliable <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> assessment. <i>De novo</i> variants are known to occur at a low but appreciable rate in <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorders [<a class="bk_pop" href="#spg11.REF.j_nsson.2017.519">J&#x000f3;nsson et al 2017</a>].)</div><div class="half_rhythm">In one rare case, a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> inherited one <i>SPG11</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> parent and the second pathogenic variant occurred <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> in the proband (i.e., only one parent was a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>) [<a class="bk_pop" href="#spg11.REF.denora.2010.501">Denora et al 2010</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Heterozygotes (carriers) are typically asymptomatic but abnormal ocular fundus may occasionally be observed [<a class="bk_pop" href="#spg11.REF.puech.2011.564">Puech et al 2011</a>].</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>If each parent is known to be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for an <i>SPG11</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has at conception a 25% chance of being affected, a 50% chance of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Intrafamilial clinical variability is observed in SPG11; age at onset and associated clinical manifestations may vary among affected sibs.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are typically asymptomatic but abnormal ocular fundus may occasionally be observed [<a class="bk_pop" href="#spg11.REF.puech.2011.564">Puech et al 2011</a>].</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with SPG11 are obligate heterozygotes (carriers) of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SPG11</i>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SPG11</i>.</p></div><div id="spg11.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>SPG11</i> pathogenic variants in the family.</p></div><div id="spg11.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="spg11.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Testing</h3><p>Once the pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-testing/">preimplantation genetic testing</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="spg11.Resources"><h2 id="_spg11_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>EURO HSP</b></div><div>Plateforme Maladies Rares</div><div>99 Rue Didot</div><div>Paris 75014</div><div>France</div><div><b>Phone:</b> 33 1 56 53 52 61</div><div><b>Email:</b> president@eurohsp.eu</div><div><a href="http://www.eurohsp.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.eurohsp.eu</a></div></li><li class="half_rhythm"><div><b>HSP Research Foundation</b></div><div>P.O. Box 4064</div><div>Warrimoo New South Wales NSW 2774</div><div>Australia</div><div><a href="https://www.hspersunite.org.au/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.hspersunite.org.au</a></div></li><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div>PO Box 5801</div><div>Bethesda MD 20824</div><div><b>Phone:</b> 800-352-9424 (toll-free); 301-496-5751; 301-468-5981 (TTY)</div><div><a href="https://www.ninds.nih.gov/Disorders/All-Disorders/Hereditary-Spastic-Paraplegia-Information-Page" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hereditary Spastic Paraplegia Information Page</a></div></li><li class="half_rhythm"><div><b>Spastic Paraplegia Foundation, Inc.</b></div><div>7700 Leesburg Pike</div><div>Ste 123</div><div>Falls Church VA 22043</div><div><b>Phone:</b> 877-773-4483 (toll-free)</div><div><b>Email:</b> information@sp-foundation.org</div><div><a href="http://sp-foundation.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">sp-foundation.org</a></div></li><li class="half_rhythm"><div><b>Tom Wahlig-Foundation</b></div><div>Tom Wahlig Stiftung</div><div>B&#x000fc;ro Veghestrasse 22</div><div>Germany</div><div><b>Phone:</b> 49 (0) 251 - 20 07 91 20</div><div><b>Email:</b> nfo@hsp-info.de</div><div><a href="http://www.hsp-info.de/en/foundation.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.hsp-info.de/en/foundation.htm</a></div></li><li class="half_rhythm"><div><b>A.I. Vi.P.S.</b></div><div>Associazione Italiana Vivere la Paraparesi Spastica Onlus</div><div>Via Tevere, 7</div><div>20020 Lainate (MI)</div><div>Italy</div><div><b>Phone:</b> 39 392 9825622</div><div><b>Email:</b> nfo@vipsonlus.it</div><div><a href="http://www.vipsonlus.it/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.vipsonlus.it</a></div></li><li class="half_rhythm"><div><b>EURORDIS-Rare Diseases Europe</b></div><div><i>The Voice of Rare Disease Patients in Europe</i></div><div>The Voice of Rare Disease Patients in Europe</div><div>Plateforme Maladies Rares</div><div>96, rue Didot</div><div>Paris 75014 </div><div>France</div><div><b>Phone:</b> 33 1 56 53 52 10</div><div><b>Fax:</b> 33 1 56 53 52 15</div><div><b>Email:</b> eurordis@eurordis.org</div><div><a href="https://www.eurordis.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.eurordis.org</a></div></li></ul></div><div id="spg11.Molecular_Genetics"><h2 id="_spg11_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="spg11.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Spastic Paraplegia 11: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1210/table/spg11.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__spg11.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_spg11.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Locus Name</th><th id="hd_b_spg11.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_spg11.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_spg11.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_spg11.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_spg11.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_spg11.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_spg11.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">SPG11</td><td headers="hd_b_spg11.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/80208" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SPG11</i></a></td><td headers="hd_b_spg11.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=80208" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">15q21<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_spg11.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q96JI7" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Spatacsin</a></td><td headers="hd_b_spg11.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/SPG11" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SPG11 database</a></td><td headers="hd_b_spg11.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SPG11" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SPG11</a></td><td headers="hd_b_spg11.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SPG11[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SPG11</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="spg11.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="spg11.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Spastic Paraplegia 11 (<a href="/omim/604360,610844" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1210/table/spg11.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__spg11.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/604360" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">604360</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/610844" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">610844</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPG11 GENE; SPG11</td></tr></tbody></table></div></div><div id="spg11.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p><b>Introduction.</b>
<i>SPG11</i> encodes spatacsin, a protein strongly conserved through evolution. Neither <i>SPG11</i> nor spatacsin shows any significant sequence similarity to known <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> or protein sequences. The spatacsin protein interacts with the SPG15 and SPG48 protein products [<a class="bk_pop" href="#spg11.REF.s_abicki.2010.e1000408">S&#x00142;abicki et al 2010</a>] and is an accessory protein of the adaptor protein 5 complex [<a class="bk_pop" href="#spg11.REF.hirst.2011.e1001170">Hirst et al 2011</a>]. It is required for proper lysosomal tubulation and recycling [<a class="bk_pop" href="#spg11.REF.chang.2014.5249">Chang et al 2014</a>].</p><p><b>Mechanism of disease causation.</b> Most pathogenic variants identified to date in <i>SPG11</i> predict truncation of the protein, demonstrating that pathogenicity results from loss of spatacsin function. The few disease-associated <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants are likely to result in partial loss of spatacsin function since the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is often milder.</p><p>The loss of spatacsin function is associated with reduced clearance of lipids from lysosomes with accumulation of gangliosides and cholesterol [<a class="bk_pop" href="#spg11.REF.boutry.2018.3813">Boutry et al 2018</a>, <a class="bk_pop" href="#spg11.REF.boutry.2019.380">Boutry et al 2019</a>]. Consequently, cholesterol levels on membranes and calcium homeostasis are altered [<a class="bk_pop" href="#spg11.REF.boutry.2019.380">Boutry et al 2019</a>]. Spatacsin is also required for neurite formation [<a class="bk_pop" href="#spg11.REF.martin.2012.299">Martin et al 2012</a>] and the GSK3b signaling pathway [<a class="bk_pop" href="#spg11.REF.pozner.2018.914">Pozner et al 2018</a>]. These data provide potential targets for preclinical studies.</p></div></div><div id="spg11.References"><h2 id="_spg11_References_">References</h2><div id="spg11.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.anheim.2009.104">Anheim M, Lagier-Tourenne C, Stevanin G, Fleury M, Durr A, Namer IJ, Denora P, Brice A, Mandel JL, Koenig M, Tranchant C. SPG11 spastic paraplegia. A new cause of juvenile parkinsonism. <span><span class="ref-journal">J Neurol. </span>2009;<span class="ref-vol">256</span>:104–8.</span> [<a href="/pubmed/19224311" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19224311</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.boukhris.2009.527">Boukhris A, Stevanin G, Feki I, Denora P, Elleuch N, Miladi MI, Goizet C, Truchetto J, Belal S, Brice A, Mhiri C. Tunisian hereditary spastic paraplegias: clinical variability supported by genetic heterogeneity. <span><span class="ref-journal">Clin Genet. </span>2009;<span class="ref-vol">75</span>:527–36.</span> [<a href="/pubmed/19438933" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19438933</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.boutry.2019.380">Boutry M, Pierga A, Matusiak R, Branchu J, Houllegatte M, Ibrahim Y, Balse E, El Hachimi KH, Brice A, Stevanin G, Darios F. Loss of spatacsin impairs cholesterol trafficking and calcium homeostasis. <span><span class="ref-journal">Commun Biol. </span>2019;<span class="ref-vol">2</span>:380.</span> [<a href="/pmc/articles/PMC6797781/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6797781</span></a>] [<a href="/pubmed/31637311" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 31637311</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.boutry.2018.3813">Boutry M, Branchu J, Lustremant C, Pujol C, Pernelle J, Matusiak R, Seyer A, Poirel M, Chu-Van E, Pierga A, Dobrenis K, Puech JP, Caillaud C, Durr A, Brice A, Colsch B, Mochel F, El Hachimi KH, Stevanin G, Darios F. Inhibition of lysosome membrane recycling causes accumulation of gangliosides that contribute to neurodegeneration. <span><span class="ref-journal">Cell Rep. </span>2018;<span class="ref-vol">23</span>:3813–26.</span> [<a href="/pmc/articles/PMC6045775/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6045775</span></a>] [<a href="/pubmed/29949766" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29949766</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.chang.2014.5249">Chang J, Lee S, Blackstone C. Spastic paraplegia proteins spastizin and spatacsin mediate autophagic lysosome reformation. <span><span class="ref-journal">J Clin Invest. </span>2014;<span class="ref-vol">124</span>:5249–62.</span> [<a href="/pmc/articles/PMC4348974/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4348974</span></a>] [<a href="/pubmed/25365221" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25365221</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.daoud.2012.839.e5">Daoud H, Zhou S, Noreau A, Sabbagh M, Belzil V, Dionne-Laporte A, Tranchant C, Dion P, Rouleau GA. Exome sequencing reveals SPG11 mutations causing juvenile ALS. <span><span class="ref-journal">Neurobiol Aging. </span>2012;<span class="ref-vol">33</span>:839.e5–9.</span> [<a href="/pubmed/22154821" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22154821</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.denora.2016.1723">Denora PS, Smets K, Zolfanelli F, Ceuterick-de Groote C, Casali C, Deconinck T, Sieben A, Gonzales M, Zuchner S, Darios F, Peeters D, Brice A, Malandrini A, De Jonghe P, Santorelli FM, Stevanin G, Martin JJ, El Hachimi KH. Motor neuron degeneration in spastic paraplegia 11 mimics amyotrophic lateral sclerosis lesions. <span><span class="ref-journal">Brain. </span>2016;<span class="ref-vol">139</span>:1723–34.</span> [<a href="/pmc/articles/PMC5839621/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5839621</span></a>] [<a href="/pubmed/27016404" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27016404</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.denora.2010.501">Denora PS, Brockmann K, Ciccolella M, Truchetto J, Stevanin G, Santorelli FM. Identification of a de novo mutation in SPG11. <span><span class="ref-journal">Mov Disord. </span>2010;<span class="ref-vol">25</span>:501–3.</span> [<a href="/pubmed/20108361" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20108361</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.denora.2009.e500">Denora PS, Schlesinger D, Casali C, Kok F, Tessa A, Boukhris A, Azzedine H, Dotti MT, Bruno C, Truchetto J, Biancheri R, Fedirko E, Di Rocco M, Bueno C, Malandrini A, Battini R, Sickl E, de Leva MF, Boespflug-Tanguy O, Silvestri G, Simonati A, Said E, Ferbert A, Criscuolo C, Heinimann K, Modoni A, Weber P, Palmeri S, Plasilova M, Pauri F, Cassandrini D, Battisti C, Pini A, Tosetti M, Hauser E, Masciullo M, Di Fabio R, Piccolo F, Denis E, Cioni G, Massa R, Della Giustina E, Calabrese O, Melone MA, De Michele G, Federico A, Bertini E, Durr A, Brockmann K, van der Knaap MS, Zatz M, Filla A, Brice A, Stevanin G, Santorelli FM. Screening of ARHSP-TCC patients expands the spectrum of SPG11 mutations and includes a large scale gene deletion. <span><span class="ref-journal">Hum Mutat. </span>2009;<span class="ref-vol">30</span>:E500–19.</span> [<a href="/pubmed/19105190" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19105190</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.faber.2018a.1650">Faber I, Martinez ARM, Martins CR Jr, Maia ML, Souza JP, Louren&#x000e7;o CM, Marques W Jr, Montecchiani C, Orlacchio A, Pedroso JL, Barsottini OGP, Ramos CD, Lopes-Cendes &#x000cd;, Friedman JH, Amorim BJ, Fran&#x000e7;a MC Jr. SPG11-related parkinsonism: Clinical profile, molecular imaging and l-dopa response. <span><span class="ref-journal">Mov Disord. </span>2018a;<span class="ref-vol">33</span>:1650–6.</span> [<a href="/pubmed/30306626" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30306626</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.faber.2018b.848">Faber I, Martinez ARM, de Rezende TJR, Martins CR Jr, Martins MP, Louren&#x000e7;o CM, Marques W Jr, Montecchiani C, Orlacchio A, Pedroso JL, Barsottini OGP, Lopes-Cendes &#x000cd;, Fran&#x000e7;a MC Jr. SPG11 mutations cause widespread white matter and basal ganglia abnormalities, but restricted cortical damage. <span><span class="ref-journal">Neuroimage Clin. </span>2018b;<span class="ref-vol">19</span>:848–57.</span> [<a href="/pmc/articles/PMC6008284/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6008284</span></a>] [<a href="/pubmed/29946510" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29946510</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.fran_a.2012.828">Fran&#x000e7;a MC Jr, Yasuda CL, Pereira FR, D'Abreu A, Lopes-Ramos CM, Rosa MV, Cendes F, Lopes-Cendes I. White and grey matter abnormalities in patients with SPG11 mutations. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2012;<span class="ref-vol">83</span>:828–33.</span> [<a href="/pubmed/22696581" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22696581</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.g_nther.2016.703">G&#x000fc;nther S, Elert-Dobkowska E, Soehn AS, Hinreiner S, Yoon G, Heller R, Hellenbroich Y, H&#x000fc;bner CA, Ray PN, Hehr U, Bauer P, Sulek A, Beetz C. High Frequency of Pathogenic Rearrangements in SPG11 and Extensive Contribution of Mutational Hotspots and Founder Alleles. <span><span class="ref-journal">Hum Mutat. </span>2016;<span class="ref-vol">37</span>:703–9.</span> [<a href="/pubmed/27071356" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27071356</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.hehr.2007.656">Hehr U, Bauer P, Winner B, Schule R, Olmez A, Koehler W, Uyanik G, Engel A, Lenz D, Seibel A, Hehr A, Ploetz S, Gamez J, Rolfs A, Weis J, Ringer TM, Bonin M, Schuierer G, Marienhagen J, Bogdahn U, Weber BH, Topaloglu H, Schols L, Riess O, Winkler J. Long-term course and mutational spectrum of spatacsin-linked spastic paraplegia. <span><span class="ref-journal">Ann Neurol. </span>2007;<span class="ref-vol">62</span>:656–65.</span> [<a href="/pubmed/18067136" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18067136</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.hirst.2011.e1001170">Hirst J, Barlow LD, Francisco GC, Sahlender DA, Seaman MN, Dacks JB, Robinson MS. The fifth adaptor protein complex. <span><span class="ref-journal">PLoS Biol. </span>2011;<span class="ref-vol">9</span>:e1001170</span> [<a href="/pmc/articles/PMC3191125/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3191125</span></a>] [<a href="/pubmed/22022230" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22022230</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.j_nsson.2017.519">J&#x000f3;nsson H, Sulem P, Kehr B, Kristmundsdottir S, Zink F, Hjartarson E, Hardarson MT, Hjorleifsson KE, Eggertsson HP, Gudjonsson SA, Ward LD, Arnadottir GA, Helgason EA, Helgason H, Gylfason A, Jonasdottir A, Jonasdottir A, Rafnar T, Frigge M, Stacey SN, Th Magnusson O, Thorsteinsdottir U, Masson G, Kong A, Halldorsson BV, Helgason A, Gudbjartsson DF, Stefansson K. Parental influence on human germline de novo mutations in 1,548 trios from Iceland. <span><span class="ref-journal">Nature. </span>2017;<span class="ref-vol">549</span>:519–22.</span> [<a href="/pubmed/28959963" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28959963</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.kara.2016.1904">Kara E, Tucci A, Manzoni C, Lynch DS, Elpidorou M, Bettencourt C, Chelban V, Manole A, Hamed SA, Haridy NA, Federoff M, Preza E, Hughes D, Pittman A, Jaunmuktane Z, Brandner S, Xiromerisiou G, Wiethoff S, Schottlaender L, Proukakis C, Morris H, Warner T, Bhatia KP, Korlipara LV, Singleton AB, Hardy J, Wood NW, Lewis PA, Houlden H. Genetic and phenotypic characterization of complex hereditary spastic paraplegia. <span><span class="ref-journal">Brain. </span>2016;<span class="ref-vol">139</span>:1904–18.</span> [<a href="/pmc/articles/PMC4939695/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4939695</span></a>] [<a href="/pubmed/27217339" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27217339</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.kawarai.2015.250">Kawarai T, Miyamoto R, Mori A, Oki R, Tsukamoto-Miyashiro A, Matsui N, Miyazaki Y, Orlacchio A, Izumi Y, Nishida Y, Kaji R. Late-onset spastic paraplegia: Aberrant SPG11 transcripts generated by a novel splice site donor mutation. <span><span class="ref-journal">J Neurol Sci. </span>2015;<span class="ref-vol">359</span>:250–5.</span> [<a href="/pubmed/26671123" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26671123</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.manole.2016.2278">Manole A, Chelban V, Haridy NA, Hamed SA, Berardo A, Reilly MM, Houlden H. Severe axonal neuropathy is a late manifestation of SPG11. <span><span class="ref-journal">J Neurol. </span>2016;<span class="ref-vol">263</span>:2278–86.</span> [<a href="/pmc/articles/PMC5065903/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5065903</span></a>] [<a href="/pubmed/27544499" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27544499</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.martin.2012.299">Martin E, Yanicostas C, Rastetter A, Naini SM, Maouedj A, Kabashi E, Rivaud-P&#x000e9;choux S, Brice A, Stevanin G, Soussi-Yanicostas N. Spatacsin and spastizin act in the same pathway required for proper spinal motor neuron axon outgrowth in zebrafish. <span><span class="ref-journal">Neurobiol Dis. </span>2012;<span class="ref-vol">48</span>:299–308.</span> [<a href="/pubmed/22801083" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22801083</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.montecchiani.2016.73">Montecchiani C, Pedace L, Lo Giudice T, Casella A, Mearini M, Gaudiello F, Pedroso JL, Terracciano C, Caltagirone C, Massa R, St George-Hyslop PH, Barsottini OG, Kawarai T, Orlacchio A. ALS5/SPG11/KIAA1840 mutations cause autosomal recessive axonal Charcot-Marie-Tooth disease. <span><span class="ref-journal">Brain. </span>2016;<span class="ref-vol">139</span>:73–85.</span> [<a href="/pmc/articles/PMC5839554/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5839554</span></a>] [<a href="/pubmed/26556829" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26556829</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.morais.2017.1217">Morais S, Raymond L, Mairey M, Coutinho P, Brand&#x000e3;o E, Ribeiro P, Loureiro JL, Sequeiros J, Brice A, Alonso I, Stevanin G. Massive sequencing of 70 genes reveals a myriad of missing genes or mechanisms to be uncovered in hereditary spastic paraplegias. <span><span class="ref-journal">Eur J Hum Genet. </span>2017;<span class="ref-vol">25</span>:1217–28.</span> [<a href="/pmc/articles/PMC5643959/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5643959</span></a>] [<a href="/pubmed/28832565" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28832565</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.mukai.2018.3183">Mukai M, Koh K, Ohnuki Y, Nagata E, Takiyama Y, Takizawa S. Novel SPG11 mutations in a patient with symptoms mimicking multiple sclerosis. <span><span class="ref-journal">Intern Med. </span>2018;<span class="ref-vol">57</span>:3183–6.</span> [<a href="/pmc/articles/PMC6262711/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6262711</span></a>] [<a href="/pubmed/29877287" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29877287</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.orlacchio.2010.591">Orlacchio A, Babalini C, Borreca A, Patrono C, Massa R, Basaran S, Munhoz RP, Rogaeva EA, St George-Hyslop PH, Bernardi G, Kawarai T. SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. <span><span class="ref-journal">Brain. </span>2010;<span class="ref-vol">133</span>:591–8.</span> [<a href="/pmc/articles/PMC2822627/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2822627</span></a>] [<a href="/pubmed/20110243" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20110243</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.orl_n.2009.984">Orl&#x000e9;n H, Melberg A, Raininko R, Kumlien E, Entesarian M, S&#x000f6;derberg P, P&#x000e5;hlman M, Darin N, Kyllerman M, Holmberg E, Engler H, Eriksson U, Dahl N. SPG11 mutations cause Kjellin syndrome, a hereditary spastic paraplegia with thin corpus callosum and central retinal degeneration. <span><span class="ref-journal">Am J Med Genet B Neuropsychiatr Genet. </span>2009;<span class="ref-vol">150B</span>:984–92.</span> [<a href="/pubmed/19194956" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19194956</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF._zo_uz.2015.1764.e9">&#x000d6;zo&#x0011f;uz A, Uyan &#x000d6;, Birdal G, Iskender C, Kartal E, Lahut S, &#x000d6;m&#x000fc;r &#x000d6;, Agim ZS, Eken AG, Sen NE, Kavak P, Sayg&#x00131; C, Sapp PC, Keagle P, Parman Y, Tan E, Ko&#x000e7; F, Deymeer F, Oflazer P, Hana&#x0011f;as&#x00131; H, G&#x000fc;rvit H, Bilgi&#x000e7; B, Durmu&#x0015f; H, Erta&#x0015f; M, Kotan D, Akal&#x00131;n MA, G&#x000fc;ll&#x000fc;o&#x0011f;lu H, Zarifo&#x0011f;lu M, Aysal F, D&#x000f6;&#x0015f;o&#x0011f;lu N, Bilguvar K, G&#x000fc;nel M, Keskin &#x000d6;, Akg&#x000fc;n T, &#x000d6;z&#x000e7;elik H, Landers JE, Brown RH, Ba&#x0015f;ak AN. The distinct genetic pattern of ALS in Turkey and novel mutations. <span><span class="ref-journal">Neurobiol Aging. </span>2015;<span class="ref-vol">36</span>:1764.e9–1764.e18.</span> [<a href="/pmc/articles/PMC6591733/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6591733</span></a>] [<a href="/pubmed/25681989" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25681989</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.pascual.2019.199">Pascual B, de Bot ST, Daniels MR, Fran&#x000e7;a MC Jr, Toro C, Riverol M, Hedera P, Bassi MT, Bresolin N, van de Warrenburg BP, Kremer B, Nicolai J, Charles P, Xu J, Singh S, Patronas NJ, Fung SH, Gregory MD, Masdeu JC. "Ears of the Lynx" MRI Sign Is Associated with SPG11 and SPG15 Hereditary Spastic Paraplegia. <span><span class="ref-journal">AJNR Am J Neuroradiol. </span>2019;<span class="ref-vol">40</span>:199–203.</span> [<a href="/pubmed/30606727" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30606727</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.pozner.2018.914">Pozner T, Schray A, Regensburger M, Lie DC, Schl&#x000f6;tzer-Schrehardt U, Winkler J, Turan S, Winner B. Tideglusib rescues neurite pathology of SPG11 iPSC derived cortical neurons. <span><span class="ref-journal">Front Neurosci. </span>2018;<span class="ref-vol">12</span>:914.</span> [<a href="/pmc/articles/PMC6291617/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6291617</span></a>] [<a href="/pubmed/30574063" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30574063</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.puech.2011.564">Puech B, Lacour A, Stevanin G, Sautiere BG, Devos D, Depienne C, Denis E, Mundwiller E, Ferriby D, Vermersch P, Defoort-Dhellemmes S. Kjellin syndrome: long-term neuro-ophthalmologic follow-up and novel mutations in the SPG11 gene. <span><span class="ref-journal">Ophthalmology. </span>2011;<span class="ref-vol">118</span>:564–73.</span> [<a href="/pubmed/21035867" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21035867</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.rajakulendran.2011.102">Rajakulendran S, Pais&#x000e1;n-Ruiz C, Houlden H. Thinning of the corpus callosum and cerebellar atrophy is correlated with phenotypic severity in a family with spastic paraplegia type 11. <span><span class="ref-journal">J Clin Neurol. </span>2011;<span class="ref-vol">7</span>:102–4.</span> [<a href="/pmc/articles/PMC3131536/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3131536</span></a>] [<a href="/pubmed/21779300" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21779300</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.romagnolo.2014.e14">Romagnolo A, Masera S, Mattioda A, Superti G, Santorelli FM, Mongini T, Pinessi L, Cavalla P. Atypical hereditary spastic paraplegia mimicking multiple sclerosis associated with a novel SPG11 mutation. <span><span class="ref-journal">Eur J Neurol. </span>2014;<span class="ref-vol">21</span>:e14–5.</span> [<a href="/pubmed/24571105" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24571105</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.rubegni.2015.1987">Rubegni A, Storti E, Tessa A, Federico A, Santorelli FM. Hereditary spastic paraplegia type 11 with a very late onset. <span><span class="ref-journal">J Neurol. </span>2015;<span class="ref-vol">262</span>:1987–9.</span> [<a href="/pubmed/26183056" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26183056</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.southgate.2010.379">Southgate L, Dafou D, Hoyle J, Li N, Kinning E, Critchley P, N&#x000e9;meth AH, Talbot K, Bindu PS, Sinha S, Taly AB, Raghavendra S, M&#x000fc;ller F, Maher ER, Trembath RC. Novel SPG11 mutations in Asian kindreds and disruption of spatacsin function in the zebrafish. <span><span class="ref-journal">Neurogenetics. </span>2010;<span class="ref-vol">11</span>:379–89.</span> [<a href="/pmc/articles/PMC2944959/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2944959</span></a>] [<a href="/pubmed/20390432" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20390432</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.s_abicki.2010.e1000408">S&#x00142;abicki M, Theis M, Krastev DB, Samsonov S, Mundwiller E, Junqueira M, Paszkowski-Rogacz M, Teyra J, Heninger AK, Poser I, Prieur F, Truchetto J, Confavreux C, Marelli C, Durr A, Camdessanche JP, Brice A, Shevchenko A, Pisabarro MT, Stevanin G, Buchholz F. A genome-scale DNA repair RNAi screen identifies SPG48 as a novel gene associated with hereditary spastic paraplegia. <span><span class="ref-journal">PLoS Biol. </span>2010;<span class="ref-vol">8</span>:e1000408</span> [<a href="/pmc/articles/PMC2893954/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2893954</span></a>] [<a href="/pubmed/20613862" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20613862</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.stevanin.2008.772">Stevanin G, Azzedine H, Denora P, Boukhris A, Tazir M, Lossos A, Rosa AL, Lerer I, Hamri A, Alegria P, Loureiro J, Tada M, Hannequin D, Anheim M, Goizet C, Gonzalez-Martinez V, Le Ber I, Forlani S, Iwabuchi K, Meiner V, Uyanik G, Erichsen AK, Feki I, Pasquier F, Belarbi S, Cruz VT, Depienne C, Truchetto J, Garrigues G, Tallaksen C, Tranchant C, Nishizawa M, Vale J, Coutinho P, Santorelli FM, Mhiri C, Brice A, Durr A. Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. <span><span class="ref-journal">Brain. </span>2008;<span class="ref-vol">131</span>:772–84.</span> [<a href="/pubmed/18079167" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18079167</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg11.REF.stevanin.2007.366">Stevanin G, Santorelli FM, Azzedine H, Coutinho P, Chomilier J, Denora PS, Martin E, Ouvrard-Hernandez AM, Tessa A, Bouslam N, Lossos A, Charles P, Loureiro JL, Elleuch N, Confavreux C, Cruz VT, Ruberg M, Leguern E, Grid D, Tazir M, Fontaine B, Filla A, Bertini E, Durr A, Brice A. Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. <span><span class="ref-journal">Nat Genet. </span>2007;<span class="ref-vol">39</span>:366–72.</span> [<a href="/pubmed/17322883" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17322883</span></a>]</div></li></ul></div></div><div id="spg11.Chapter_Notes"><h2 id="_spg11_Chapter_Notes_">Chapter Notes</h2><div id="spg11.Author_Notes"><h3>Author Notes</h3><p>Giovanni Stevanin, PhD is a molecular biologist with expertise in spinocerebellar degeneration. He is Director of Research at INSERM and Professor at the Ecole Pratique des Hautes Etudes / Paris Sciences Lettres University. He co-leads a research team at the Institut du Cerveau et de la Moelle Epini&#x000e8;re (Paris, France) and the international network on spastic paraplegias and ataxias (SPATAX; see below).</p><p>The author suggests the following organization for patient registries and information on ataxia and spastic paraparesis:</p><p>SPATAX Network<br />Institut du Cerveau et de la Moelle Epini&#x000e8;re<br />Piti&#x000e9;-Salp&#x000ea;tri&#x000e8;re Hospital<br />47 Bd de l&#x02019;H&#x000f4;pital<br />75013 Paris, France<br />Email: spatax@icm-institute.org<br />Web: <a href="https://spatax.wordpress.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.spatax.wordpress.com</a></p></div><div id="spg11.Acknowledgments"><h3>Acknowledgments</h3><p>The author's work is financially supported by the French Agency for Research (ANR), the Spastic Paraplegia Foundation (US), the European Union through the H2020 program, the Erare program, and the French Str&#x000fc;mpell Lorrain Association (ASL).</p></div><div id="spg11.Author_History"><h3>Author History</h3><p>Alexis Brice, MD; H&#x000f4;pital Piti&#x000e9;-Salp&#x000ea;tri&#x000e8;re (2008-2019)<br />Alexandra Durr, MD, PhD; H&#x000f4;pital Piti&#x000e9;-Salp&#x000ea;tri&#x000e8;re (2008-2019)<br />Giovanni Stevanin, PhD (2008-present)</p></div><div id="spg11.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>19 December 2019 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>31 January 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>3 September 2009 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> available clinically</div></li><li class="half_rhythm"><div>27 March 2008 (me) Review posted live</div></li><li class="half_rhythm"><div>26 November 2007 (gs) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1210</span><span class="label">PMID: <a href="/pubmed/20301389" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301389</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/spg8/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/kennedy/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1210&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1210/?report=reader">PubReader</a></li><li><a href="/books/NBK1210/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1210" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1210" style="display:none" title="Cite this Page"><div class="bk_tt">Stevanin G. Spastic Paraplegia 11. 2008 Mar 27 [Updated 2019 Dec 19]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1210/pdf/Bookshelf_NBK1210.pdf">PDF version of this page</a> (439K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#spg11.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#spg11.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#spg11.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#spg11.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#spg11.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#spg11.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#spg11.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#spg11.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#spg11.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#spg11.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#spg11.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=80208[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SPG11</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1210+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1486644" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1486644" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1486644" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1486644" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301286" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spastic Paraplegia 7</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spastic Paraplegia 7<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Casari G, Marconi R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301339" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spastic Paraplegia 4</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spastic Paraplegia 4<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Parodi L, Rydning SL, Tallaksen C, Durr A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30543385" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> AP-4-Associated Hereditary Spastic Paraplegia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> AP-4-Associated Hereditary Spastic Paraplegia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ebrahimi-Fakhari D, Behne R, Davies AK, Hirst J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301432" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> ARSACS</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> ARSACS<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Vermeer S, van de Warrenburg BP, Kamsteeg EJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301421" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ALS2</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ALS2</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Orrell RW. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301389" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301389" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e042a6f75f66d18aa00bafa">Spastic Paraplegia 11 - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Spastic Paraplegia 11 - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T22:35:11-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE88938CE04223D10000000003990163&amp;ncbi_session=CE88938CE042A6F1_0921SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1210%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1210&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1210/&amp;ncbi_pagename=Spastic Paraplegia 11 - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE88938CE042A6F1_0921SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>